This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
O’Sullivan BP, Freedman SD Cystic fibrosis. Lancet, 2009, 373: 1891–1904. doi:10.1016/S0140-6736(09)60327-5O’SullivanBPFreedmanSDCystic fibrosis20093731891190410.1016/S0140-6736(09)60327-5Open DOISearch in Google Scholar
De Boeck K, Amaral MD Progress in therapies for cystic fibrosis. The Lancet. Respiratory medicine, 2016, 4(8), 662–674. https://doi.org/10.1016/S2213-2600(16)00023-0De BoeckKAmaralMDProgress in therapies for cystic fibrosis201648662674https://doi.org/10.1016/S2213-2600(16)00023-0Search in Google Scholar
Sousa M, Servidoni MF, Vinagre AM, et al. Measurements of CFTR-mediated Cl- secretion in human rectal biopsies constitute a robust biomarker for Cystic Fibrosis diagnosis and prognosis. PLoS One. 2012; 7(10): e47708. doi:10.1371/journal.pone.0047708SousaMServidoniMFVinagreAMMeasurements of CFTR-mediated Cl- secretion in human rectal biopsies constitute a robust biomarker for Cystic Fibrosis diagnosis and prognosis2012710e4770810.1371/journal.pone.0047708Open DOISearch in Google Scholar
Tur-Kaspa I, Aljadeff G, Rechitsky S, Grotjan HE, Verlinsky Y. PGD for all cystic fibrosis carrier couples: novel strategy for preventive medicine and cost analysis. Reprod Biomed Online. 2010; 21(2): 186–195. doi:10.1016/j.rbmo.2010.04.031Tur-KaspaIAljadeffGRechitskySGrotjanHEVerlinskyYPGD for all cystic fibrosis carrier couples: novel strategy for preventive medicine and cost analysis201021218619510.1016/j.rbmo.2010.04.031Open DOISearch in Google Scholar
Heitman E. Social and ethical aspects of in vitro fertilization. International Journal of Technology Assessment in Health Care. 1999; 15(1): 22–35. doi:10.1017/S0266462399015184HeitmanESocial and ethical aspects of in vitro fertilization1999151223510.1017/S0266462399015184Open DOISearch in Google Scholar
Petrova G, Yaneva N, Hrbková J, Libik M, Savov A, Macek M Jr. Identification of 99% of CFTR gene mutations in Bulgarian-, Bulgarian Turk-, and Roma cystic fibrosis patients. Mol Genet Genomic Med. 2019; 7(8): e696. doi:10.1002/mgg3.696PetrovaGYanevaNHrbkováJLibikMSavovAMacekMJr.Identification of 99% of CFTR gene mutations in Bulgarian-, Bulgarian Turk-, and Roma cystic fibrosis patients201978e69610.1002/mgg3.696Open DOISearch in Google Scholar
Cruz I, Marciel KK, Quittner AL, Schechter MS. Anxiety and depression in cystic fibrosis. Semin Respir Crit Care Med. 2009 Oct; 30(5): 569–78. doi: 10.1055/s-0029-1238915.CruzIMarcielKKQuittnerALSchechterMSAnxiety and depression in cystic fibrosis2009Oct3055697810.1055/s-0029-1238915Open DOISearch in Google Scholar
Taylor-Cousar JL. CFTR Modulators: Impact on Fertility, Pregnancy, and Lactation in Women with Cystic Fibrosis. J Clin Med. 2020 Aug 21; 9(9): 2706. doi: 10.3390/jcm9092706. PMID: 32825766; PMCID: PMC7563981.Taylor-CousarJLCFTR Modulators: Impact on Fertility, Pregnancy, and Lactation in Women with Cystic Fibrosis2020Aug2199270610.3390/jcm909270632825766PMC7563981Open DOISearch in Google Scholar
Handyside AH, Lesko JG, Tarin JJ, Winston RM, Hughes MR Birth of a normal girl after in vitro fertilization and preimplantation diagnostic testing for cystic fibrosis. N Engl J Med. 1992; 327: 905–909HandysideAHLeskoJGTarinJJWinstonRMHughesMRBirth of a normal girl after in vitro fertilization and preimplantation diagnostic testing for cystic fibrosis1992327905909Search in Google Scholar
Petanovska Kostova E. The Interaction of Female Age and Active Male Smoking has Negative Influence on Success Rates of the in Vitro Fertilization Treatments. Balkan J Med Genet. 2020; 23(1): 57–62. Published 2020 Aug 26. doi:10.2478/bjmg-2020-0005Petanovska KostovaEThe Interaction of Female Age and Active Male Smoking has Negative Influence on Success Rates of the in Vitro Fertilization Treatments20202315762Published 2020 Aug 26.10.2478/bjmg-2020-0005Open DOISearch in Google Scholar
Field PD, Martin NJ. CFTR mutation screening in an assisted reproductive clinic. Aust N Z J Obstet Gynaecol. 2011; 51(6): 536–539. doi:10.1111/j.1479-828X.2011.01348.xFieldPDMartinNJCFTR mutation screening in an assisted reproductive clinic201151653653910.1111/j.1479-828X.2011.01348.xOpen DOISearch in Google Scholar
Rongioletti M., Papa F, Majolini MB, Vaccarella C, Simonelli I, Luciano A et al. 15 Frequency of mutations of the cystic fibrosis transmembrane regulator (CFTR) gene in a cohort of consecutive patients candidate for assisted reproductive techniques J Cyst Fibros, 2012 Volume 11, S59RongiolettiMPapaFMajoliniMBVaccarellaCSimonelliILucianoA15 Frequency of mutations of the cystic fibrosis transmembrane regulator (CFTR) gene in a cohort of consecutive patients candidate for assisted reproductive techniques201211S59Search in Google Scholar
Picci L, Cameran M, Marangon O, et al. A 10-year large-scale cystic fibrosis carrier screening in the Italian population. J Cyst Fibros. 2010; 9(1): 29–35. doi:10.1016/j.jcf.2009.10.003PicciLCameranMMarangonOA 10-year large-scale cystic fibrosis carrier screening in the Italian population201091293510.1016/j.jcf.2009.10.003Open DOISearch in Google Scholar
Massie J, Forbes R, Dusart D, Bankier A, Delatycki MB. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis. J Paediatr Child Health. 2007; 43(11): 721–723. doi:10.1111/j.1440-1754.2007.01224.xMassieJForbesRDusartDBankierADelatyckiMBCommunity-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis2007431172172310.1111/j.1440-1754.2007.01224.xOpen DOISearch in Google Scholar
Wilcken B. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis. J Paediatr Child Health. 2008; 44(4): 232–233. doi:10.1111/j.1440-1754.2008.01293.xWilckenBCommunity-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis200844423223310.1111/j.1440-1754.2008.01293.xOpen DOISearch in Google Scholar
Fustik S, Anastasovska V, Plaseska-Karanfilska D, et al. Two Years of Newborn Screening for Cystic Fibrosis in North Macedonia: First Experience. Balkan J Med Genet. 2021; 24(1): 41–46. Published 2021 Jul 27. doi:10.2478/bjmg-2021-0015FustikSAnastasovskaVPlaseska-KaranfilskaDTwo Years of Newborn Screening for Cystic Fibrosis in North Macedonia: First Experience20212414146Published 2021 Jul 27.10.2478/bjmg-2021-0015Open DOISearch in Google Scholar
Savov A, Genetic defects in Bulgarian cystic fibrosis patients, Inspiro 2011, 15(3) (Bul.)SavovAGenetic defects in Bulgarian cystic fibrosis patients2011153(Bul.)Search in Google Scholar
Tanriverdi S, Polat M, Onay H. Determination of Cystic Fibrosis Mutation Frequency in Preterm and Term Neonates with Respiratory Tract Problems. Balkan J Med Genet. 2022; 24(2): 25–31. Published 2022 Jun 5. doi:10.2478/bjmg-2021-0023TanriverdiSPolatMOnayHDetermination of Cystic Fibrosis Mutation Frequency in Preterm and Term Neonates with Respiratory Tract Problems20222422531Published 2022 Jun 5.10.2478/bjmg-2021-0023Open DOISearch in Google Scholar
Castellani C, Massie J. Newborn screening and carrier screening for cystic fibrosis: alternative or complementary?. Eur Respir J. 2014; 43(1): 20–23. doi:10.1183/09031936.00125613CastellaniCMassieJNewborn screening and carrier screening for cystic fibrosis: alternative or complementary?2014431202310.1183/09031936.00125613Open DOISearch in Google Scholar
S. Yaneva, S. Staikova, R. Staneva, G. Stamenov, D. Toncheva, S. Hadgidekova. Preimplantation genetic tests in in-vitro embryos Akush. i ginekol., 57, 2018, N 3, ISSN 0324-0959, 16–24 (Bul)YanevaS.StaikovaS.StanevaR.StamenovG.TonchevaD.HadgidekovaS.Preimplantation genetic tests in in-vitro embryos5720183ISSN 0324-0959,1624(Bul)Search in Google Scholar